Durability of protection and immunogenicity of AZD1222 (ChAdOx1 nCoV-19) COVID-19 vaccine over 6 months is a research paper published in Journal of Clinical Investigation (2022). On theSindex it has a DataRank of 1.1. It has been cited 33 times, with 19 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.529
From this paper's citation signal
Citation Network Contribution
0.561
From 15 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 19 citers.
AstraZeneca, funded in whole or in part under an agreement with the US Government
Grant: W15QKN-20-9-1003,W15QKN-21-9-1003,UM1 AI 148684,UM1 AI 148450,UM1 AI 148372,
AstraZeneca, funded in whole or in part under an agreement with the US Government
Grant: UM1 AI 148574
NIAID NIH HHS
Grant: UM1 AI068635
NIAID NIH HHS
Grant: UM1 AI068636
NIAID NIH HHS
Grant: UM1 AI068614
NIAID NIH HHS
Grant: UM1 AI069412
NIAID NIH HHS
Grant: UM1 AI069470
NIAID NIH HHS
Grant: UM1 AI148684
NIAID NIH HHS
Grant: UM1 AI068618
NIAID NIH HHS
Grant: UM1 AI148372
NIAID NIH HHS
Grant: UM1 AI068619
NIAID NIH HHS
Grant: UM1 AI148450
MeSH Terms
Keywords